ChengDu ShengNuo Biotec Co.,Ltd. (688117.SS)

CNY 26.37

(-2.08%)

Market Cap (In CNY)

2.96 Billion

Revenue (In CNY)

430.98 Million

Net Income (In CNY)

70.33 Million

Avg. Volume

4.34 Million

Currency
CNY
Country
Healthcare
Open
-
Prev. Close
-
Day Range
-
Year Range
16.46-36.98
PE
32.16
EPS
0.82
Beta Value
0.688
ISIN
CNE1000051M8
CUSIP
-
CIK
-
Shares
112419000.0
Earnings Annoncement
-

Company Profile

Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
CEO
Mr. Yongjun Wen
Employee Count
-
Website
https://www.snbiopharm.com
Ipo Date
2021-06-03
Details
ChengDu ShengNuo Biotec Co.,Ltd. engages in the research and development, production, sale, and export of peptide drugs. The company produces polypeptide APIs, tablets of solid preparation, bottles of freeze-dried powder injections, small-volume injections, pre-filled injections, and card type injections. ChengDu ShengNuo Biotec Co.,Ltd. was founded in 2001 and is based in Chengdu, China.